Antimicrobial efficacy of the silver wound dressing Biatain Ag in a disc carrier test simulating wound secretion

Skin Pharmacology and Physiology

Volumn 24, Issue 6, 2011, Pages 337-341

  Ebert, M ^a   Assadian, O ^c   Hubner N O ^a   Koburger, T ^b   Kramer, A ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b HYGIENE NORD GMBH   (Germany)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antimicrobial efficacy; Biatain Ag; Silver wound dressing; Wound secretion

Indexed keywords

ANTIINFECTIVE AGENT; PHOSPHATE BUFFERED SALINE; SILVER; THIOGLYCOLIC ACID;

AGAR DILUTION; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CONTAMINATION; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; FOAM DRESSING; IMMUNOHISTOCHEMISTRY; LEACHING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUANTITATIVE ANALYSIS; ROOM TEMPERATURE; STAPHYLOCOCCUS AUREUS; WOUND DRESSING; WOUND FLUID;

ANTI-INFECTIVE AGENTS; BANDAGES; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; SILVER; STAPHYLOCOCCUS AUREUS; WOUND INFECTION;

EID: 81155157648     PISSN: 16605527     EISSN: 16605535     Source Type: Journal    
DOI: 10.1159/000330761     Document Type: Article

References (11)

1. Pitten FA, Werner HP, Kramer A: A standardized test to assess the impact of different organic challenges on the antimicrobial activity of antiseptics. J Hosp Infect 2003;55:108-115. (Pubitemid 38001962)
2. Auger FA, Lacroix D, Germain L: Skin substitutes and wound healing. Skin Pharmacol Physiol 2009;22:94-102
3. Müller G, Kramer A: Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. J Antimicrob Chemother 2008;61:1281-1287. (Pubitemid 351753595)
4. Kramer A: Hand disinfection and antiseptic of skin, mucous membranes, and wounds; in Gabard B, Elsner P, Surber C, Treffel P (eds): Dermatopharmacology of Topical Preparations. Berlin, Springer, 1999, pp 121-134.
5. Kramer A, Hubner NO, Assadian O, et al: Polihexanide - perspectives on clinical wound antisepsis. Skin Pharmacol Physiol 2010;23(suppl 1):1-3.
6. Weingart D, Stoll P: The epithelization of split skin graft donor sites - a test model for the efficacy of topical wound therapeutic agents. Eur J Plast Surg 1993;16:22-25. (Pubitemid 23082717)
7. Hidalgo E, Bartolome R, Barroso C, Moreno A, Dominguez C: Silver nitrate: antimicrobial activity related to cytotoxicity in cultured human fibroblasts. Skin Pharmacol Appl Skin Physiol 1998;11:140-151. (Pubitemid 28466445)
8. Wiegand C, Heinze T, Hipler UC: Comparative in vitro study on cytotoxicity, antimicrobial activity, and binding capacity for pathophysiological factors in chronic wounds of alginate and silver-containing alginate. Wound Repair Regen 2009;17:511-521.
9. Vermeulen H, van Hattem JM, Storm-Versloot MN, Ubbink DT: Topical silver for treating infected wounds. Cochrane Database Syst Rev 2007;1: CD005486.
10. Lo SF, Chang CJ, Hu WY, Hayter M, Chang YT: The effectiveness of silver-releasing dressings in the management of non-healing chronic wounds: a meta-analysis. J Clin Nurs 2009;18:716-728.
11. Beam JW: Topical silver for infected wounds. Athl Train 2009;44:531-533.